LEADERSHIP Jump to section

Board of Directors

Our Directors are collectively responsible for the success of Ridge Crown Pharmaceutical. In addition, the Non-Executive Directors are responsible for exercising independent and objective judgement and for scrutinising and challenging management. The Board is responsible for setting our strategy and policies, oversight of risk and corporate governance and monitoring progress towards meeting our annual plans. It is accountable to our shareholders for the proper conduct of the business and our long-term success and represents the interests of all stakeholders. The Board has delegated some of its powers to five principal committees and the CEO. Members of the Board are;

  • • Philip Broadley
  • • Euan Ashley
  • • Deborah DiSanzo
  • • Michel Demaré
  • • Pascal Soriot
  • • Aradhana Sarin

Senior Executive Team

In addition to the Board of Directors, our Senior Executive Team, or SET, is the body through which our Chief Executive Officer (CEO) exercises the authority delegated to him by the Board. Our CEO leads the SET and has executive responsibility for the management, development and performance of the business. The Chief Executive Officer, Chief Financial Officer and SET also take the lead in developing our strategy for review, constructive challenge and approval by the Board as part of our annual strategy review process.

  • • Marc Dunoyer
  • • Susan Galbraith
  • • Pam Cheng
  • • David Fredrickson
  • • Pascal Soriot
  • • Aradhana Sarin